New hope for rare tumor disorder: Multi-Drug trial launches
Disease control
Recruiting now
This study tests several experimental drugs in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors in the nervous system. About 109 participants will receive one of three drug combinations to see if they can shrink tumors and control the …
Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated May 13, 2026 16:03 UTC